By Professor Jason Grebely

Reports

Wilkinson A; Griffin S; Hellard M; Stoové M; Dore G; Grebely J; Pedrana A; Doyle J; Thompson A; Hajarizadeh B; Aitken C; Broady T; Combo T, 2023, Australia’s progress towards hepatitis C elimination: Annual Report 2023, http://dx.doi.org/10.26190/4d4f-5n41

Shahbazi J; Farrell M; Byrne J; Ali R; Puszka B; Lim XQ; Cook J; Weiss R; Rodgers C; Dunlop A; Lintzeris N; Nielsen S; Grebely J; Zahra E; Degenhardt L; Byrne M, 2023, Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: Preliminary lessons from the Community Long-Acting Buprenorphine (CoLAB) trial, NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2020, RANDWICK, 355, http://dx.doi.org/10.26190/zemp-dx93

Wilkinson A; Hayes M; Hellard M; Stoové M; Dore G; Grebely J; Pedrana A; Doyle J; Thompson A; Hajarizadeh B; Alavi M; Aitken C; Broady T; Combo T, 2022, Australia's progress towards hepatitis C elimination: annual report 2022, http://dx.doi.org/10.26190/ge22-aq55

Brothers T; Degenhardt L, 2022, Time periods of altered risk for severe injection drug use-associated skin and soft-tissue infections: protocol for a self-controlled case series in New South Wales, Australia, 2001-2018, UCL Press, http://dx.doi.org/10.14324/000.rp.10157481, http://dx.doi.org/10.14324/000.rp.10157481

Bajis S; Dore G; Alavi M; McGregor S; Kwon A; Monaghan R; Iversen J; Martinello M; Buckland G; Guy R; Kaldor J; Grebely J, 2021, Progress towards hepatitis C elimination among Aboriginal and Torres Strait Islander people in Australia: monitoring and evaluation report, The Kirby Institute, UNSW Sydney, Sydney, Australia, https://kirby.unsw.edu.au/report/progress-towards-hepatitis-c-elimination-among-aboriginal-and-torres-strait-islander-people

Wilkinson A; Hellard M; Pedrana A; Alavi M; Stoove M; Doyle J; Aitken C; Dore G; Thompson A; Broady T; Grebely J; Hajarizadeh B, 2020, Australia’s progress towards hepatitis C elimination: annual report 2020, Burnet Institute and Kirby Institute, http://dx.doi.org/10.26190/unsworks/28056, https://kirby.unsw.edu.au/report/australias-progress-towards-hepatitis-c-elimination-annual-report-2020

Gibbs D; Grebely J; Larney S; Butler K; Sutherland R; Starr M; Karlsson A; Uporova J; Degenhardt L; Farrell M; Peacock A, 2019, Self-report and serological HCV status amongst people who inject drugs in NSW and ACT, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Trends Bulletin August 2019, http://dx.doi.org/10.26190/5d788a487ac61, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/4.%20DBS%20and%20HCV%20self%20report%20bulletin.pdf

Wilkinson A; Hellard M; Pedrana A; Alavi M; Stoove M; Doyle J; Aitken C; Dore G; Thompson A; Grebely J; Hajarizadeh B, 2019, Australia’s progress towards hepatitis C elimination: annual report 2019, Burnet Institute and Kirby Institute, http://dx.doi.org/10.26190/unsworks/28055, https://kirby.unsw.edu.au/report/australias-progress-towards-hepatitis-c-elimination-annual-report-2019

Kwon J; Gray R; Dore G; Grebely J; Guy R; Hajarizadeh B; Cunningham E, 2017, 2017 Estimates and Projections of the Hepatitis C Virus Epidemic in NSW: Summary Report, Sydney: Kirby Institute, UNSW Sydney

Back to profile page